Sun Life Financial INC Increases Position in Thermo Fisher Scientific Inc (TMO)

Sun Life Financial INC boosted its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 36,148.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,962 shares of the medical research company’s stock after buying an additional 11,929 shares during the period. Sun Life Financial INC’s holdings in Thermo Fisher Scientific were worth $2,092,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the business. Vanguard Group Inc. raised its position in Thermo Fisher Scientific by 2.4% during the second quarter. Vanguard Group Inc. now owns 26,600,394 shares of the medical research company’s stock valued at $4,640,970,000 after purchasing an additional 629,093 shares during the period. BlackRock Inc. raised its position in Thermo Fisher Scientific by 1.6% during the second quarter. BlackRock Inc. now owns 23,355,469 shares of the medical research company’s stock valued at $4,074,828,000 after purchasing an additional 366,584 shares during the period. State Street Corp raised its position in Thermo Fisher Scientific by 1.0% during the first quarter. State Street Corp now owns 16,085,954 shares of the medical research company’s stock valued at $2,470,802,000 after purchasing an additional 164,367 shares during the period. Wellington Management Group LLP raised its position in Thermo Fisher Scientific by 5.6% during the first quarter. Wellington Management Group LLP now owns 7,512,152 shares of the medical research company’s stock valued at $1,153,867,000 after purchasing an additional 398,622 shares during the period. Finally, Morgan Stanley raised its position in Thermo Fisher Scientific by 7.6% during the first quarter. Morgan Stanley now owns 4,664,882 shares of the medical research company’s stock valued at $716,526,000 after purchasing an additional 327,826 shares during the period. Institutional investors and hedge funds own 83.61% of the company’s stock.

A number of equities research analysts have issued reports on the company. Zacks Investment Research downgraded Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Monday, September 18th. Wells Fargo & Company restated an “outperform” rating and set a $200.00 price objective (up from $195.00) on shares of Thermo Fisher Scientific in a research report on Thursday, July 13th. Bank of America Corporation restated a “buy” rating and set a $210.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research report on Friday, July 21st. Cleveland Research upgraded Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a research report on Thursday, July 20th. Finally, BidaskClub downgraded Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. One equities research analyst has rated the stock with a hold rating and sixteen have issued a buy rating to the company. Thermo Fisher Scientific has an average rating of “Buy” and an average price target of $205.71.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.24 by $0.07. The company had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The company’s revenue was up 13.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.03 EPS.

In other news, Director C Martin Harris sold 360 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $65,149.20. Following the completion of the transaction, the director now directly owns 5,312 shares of the company’s stock, valued at approximately $961,312.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Peter E. Hornstra sold 3,894 shares of Thermo Fisher Scientific stock in a transaction dated Tuesday, September 5th. The shares were sold at an average price of $185.18, for a total transaction of $721,090.92. Following the completion of the transaction, the vice president now directly owns 19,751 shares of the company’s stock, valued at $3,657,490.18. The disclosure for this sale can be found here. Insiders sold a total of 22,738 shares of company stock valued at $4,021,512 in the last three months. Insiders own 0.49% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This report was originally reported by Community Financial News and is owned by of Community Financial News. If you are accessing this report on another site, it was stolen and republished in violation of U.S. and international copyright and trademark legislation. The original version of this report can be accessed at https://www.com-unik.info/2017/11/03/sun-life-financial-inc-increases-position-in-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

What are top analysts saying about Thermo Fisher Scientific Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Thermo Fisher Scientific Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit